Nuveen Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 474,200 shares of SRPT stock, worth $60.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

474,200

Previous 483,235 1.87%

Holding current value

$60.1 Million

Previous $76.4 Million 22.43%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $1.12 Million - $1.42 Million	-9,035 Reduced 1.87%	474,200 $59.2 Million
Q2 2024 Aug 09, 2024	SELL	$113.33 - $163.85 $6.73 Million - $9.72 Million	-59,340 Reduced 10.94%	483,235 $76.4 Million
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $873,096 - $1.32 Million	9,318 Added 1.75%	542,575 $70.2 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $1.91 Million - $3.53 Million	-28,325 Reduced 5.04%	533,257 $51.4 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $2.71 Million - $3.27 Million	-26,429 Reduced 4.49%	561,582 $68.1 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $6.06 Million - $8.96 Million	56,982 Added 10.73%	588,011 $67.3 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $21.3 Million - $28.3 Million	181,380 Added 51.87%	531,029 $73.2 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $2.3 Million - $3.01 Million	22,780 Added 6.97%	349,649 $45.3 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $554,651 - $873,552	7,326 Added 2.29%	326,869 $36.1 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $454,565 - $641,278	7,251 Added 2.32%	319,543 $24 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $2.79 Million - $3.99 Million	-44,142 Reduced 12.38%	312,292 $25.3 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $4.67 Million - $6 Million	-60,400 Reduced 14.49%	356,434 $32.1 Million
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $2.41 Million - $3.38 Million	-36,500 Reduced 8.05%	416,834 $38.5 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $5.02 Million - $6.28 Million	72,341 Added 18.99%	453,334 $35.2 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $8.43 Million - $19.7 Million	-116,634 Reduced 23.44%	380,993 $28.4 Million
Q4 2020 May 17, 2021	BUY	$125.56 - $178.74 $3.04 Million - $4.33 Million	24,226 Added 5.12%	497,627 $84.8 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $4.46 Million - $6.35 Million	35,549 Added 8.12%	473,401 $80.7 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $2.6 Million - $3.52 Million	20,430 Added 4.89%	437,852 $61.5 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $7.55 Million - $13.9 Million	81,180 Added 24.14%	417,422 $66.9 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $3.78 Million - $6.03 Million	45,838 Added 15.78%	336,242 $32.9 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $282,242 - $500,019	3,688 Added 1.29%	290,404 $37.5 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $1.71 Million - $3.68 Million	-23,458 Reduced 7.56%	286,716 $21.6 Million
Q2 2019 Aug 15, 2019	BUY	$112.21 - $151.95 $31.8 Million - $43.1 Million	283,766 Added 1074.55%	310,174 $47.1 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $2.82 Million - $4.01 Million	26,408 New	26,408 $3.15 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $277,346 - $594,165	-3,866 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$54.02 - $82.27 $896,569 - $1.37 Million	-16,597 Reduced 81.11%	3,866 $286,000
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $477,066 - $568,294	-10,014 Reduced 32.86%	20,463 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $1.09 Million - $1.44 Million	30,477	30,477 $1.38 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History